| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| HLA-L |
|
major histocompatibility complex, class I, L (pseudogene)
|
|
|
0.861 |
0.269 |
| HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| TRIM26BP |
|
tripartite motif containing 26B, pseudogene
|
|
|
0.861 |
0.269 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
| TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
| CFB |
P00751
|
complement factor B
|
|
4.7E-16 |
0.532 |
0.769 |
| MSH5 |
O43196
|
mutS homolog 5
|
Nucleic acid binding
|
3.2E-11 |
0.641 |
0.692 |
| ABCF1 |
Q8NE71
|
ATP binding cassette subfamily F member 1
|
Enzyme
|
1.3E-09 |
0.674 |
0.538 |
| STK19 |
P49842
|
serine/threonine kinase 19
|
|
6.7E-09 |
0.691 |
0.500 |
| FLOT1 |
O75955
|
flotillin 1
|
|
1.0E-08 |
0.623 |
0.692 |
| TRIM31 |
Q9BZY9
|
tripartite motif containing 31
|
|
4.3E-06 |
0.626 |
0.577 |
| HLA-DQA2 |
P01906
|
major histocompatibility complex, class II, DQ alpha 2
|
Immune response
|
1.0E-05 |
0.617 |
0.769 |
| MUCL3 |
Q3MIW9
|
mucin like 3
|
|
1.2E-05 |
0.691 |
0.731 |
| RNF39 |
Q9H2S5
|
ring finger protein 39
|
|
2.0E-05 |
0.760 |
0.538 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
| PPP1R18 |
Q6NYC8
|
protein phosphatase 1 regulatory subunit 18
|
|
5.0E-04 |
0.780 |
0.346 |
| TCF19 |
Q9Y242
|
transcription factor 19
|
|
9.4E-04 |
0.674 |
0.692 |